ストックスクリーナーアプリを入手
3.45
14.21%
-0.56
前日終値:
$4.01
開ける：
$3.7
24時間の取引高:
154.43K
Relative Volume:
0.04
時価総額：
$1.84M
収益：
$1.75M
当期純損益:
$-5.68M
株価収益率:
-0.708
EPS:
-4.8726
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-24.56%
1か月 パフォーマンス:
+90.06%
6か月 パフォーマンス:
+1,113%
1年 パフォーマンス:
+1,433%
1日の値動き範囲:
$3.3804
$3.76
1週間の範囲:
$3.3804
$4.6245
52週間の値動き範囲:
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
SPRC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
3.45 | 6.51M | 1.75M | -5.68M | 0 | -4.8726 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.04 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
473.55 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Scisparc Ltd (SPRC) 最新ニュース
Is SciSparc Ltd. stock a top momentum play2025 Geopolitical Influence & Stepwise Swing Trade Plans - newser.com
How SciSparc Ltd. stock compares to market leadersJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
Candlestick signals on SciSparc Ltd. stock todayMarket Movement Recap & Entry Point Confirmation Signals - newser.com
Is SciSparc Ltd. stock entering bullish territory2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com
Why SciSparc Ltd. stock remains on buy lists2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Price momentum metrics for SciSparc Ltd. explained2025 Major Catalysts & Daily Stock Trend Reports - newser.com
How to forecast SciSparc Ltd. trends using time seriesDip Buying & Long-Term Capital Growth Strategies - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
SciSparc And AutoMax Call Off Merger - Sahm
SciSparc and AutoMax Motors terminate merger agreement By Investing.com - Investing.com Australia
SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors - GlobeNewswire
SciSparc Ltd. cancelled the acquisition of remaining stake in Automax Motors Ltd. - MarketScreener
What candlestick patterns are forming on SciSparc Ltd.July 2025 Volume & Smart Investment Allocation Insights - newser.com
SciSparc Ltd. Terminates Merger Agreement with AutoMax Motors - TipRanks
SciSparc, AutoMax Motors mutually agree to terminate merger - TipRanks
Scisparc Ltd. announces framework agreement regarding merger with AutoMax Motors - MarketScreener
SciSparc Ltd. and AutoMax Motors Ltd. Announce Mutual Termination of Merger and Loan Repayment Agreement - Quiver Quantitative
SciSparc and AutoMax Motors terminate merger agreement - Investing.com
$4.25M Repayment Plan: SciSparc & AutoMax Mutually Terminate Merger; $2M in Monthly Repayments - Stock Titan
SciSparc’s MitoCareX Merger with N2OFF Approved by Shareholders - MSN
SciSparc Shareholders Approve Merger with AutoMax - MSN
Backtesting results for SciSparc Ltd. trading strategies2025 Market Overview & Capital Efficiency Focused Strategies - newser.com
SciSparc’s subsidiary MitoCareX approved for acquisition by N2OFF shareholders; shares up 29% - MSN
SciSparc stock surges after N2OFF shareholders approve MitoCareX acquisition - Investing.com
SciSparc Surge: Analyzing Latest Developments - StocksToTrade
SciSparc Shares Surge: Time to Invest? - timothysykes.com
Morning Market Movers: SPRC, APDN, EPSM, WOLF See Big Swings - RTTNews
SciSparc Stocks Surge 50% In Pre-Market After N2OFF Approves MitoCareX Acquisition - Nasdaq
N2OFF shareholders approve acquisition of MitoCareX Bio from SciSparc By Investing.com - Investing.com Nigeria
N2OFF shareholders approve acquisition of SciSparc subsidary - TipRanks
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s - GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
N2OFF shareholders approve acquisition of MitoCareX Bio from SciSparc - Investing.com India
SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer - GlobeNewswire
SciSparc Plans to Use Quantum Computers to Model 3D Proteins For AI Drug Discovery - The Quantum Insider
Scisparc Ltd (SPRC) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
大文字化:
|
ボリューム (24 時間):